Shire plc
|
| ||||||||||||||||||||||||
 5.60 min. | 5.0 user rating |
 0.93 min. | 0 user rating |
|
Want to Shire plc latest news on your twitter account???  Shire plc || Company || Economy |
Shire plc's CEO Discusses Q2 2011 Results - Earnings Call Transcript - Seeking Alpha  Seeking Alpha--Good day, ladies and gentlemen, and welcome to the -Shire's- 2011 Second Quarter Results Call, hosted by Angus Russell. My name is Phoebe, and I'm your event manager. [Operator Instructions] I'd like to advise all parties thi - Date : Thu, 28 Jul 2011 23:55:09 GMT+00:00 |
| Shire Plc (SHPGY) Could Break Through $101.39 Resistance Level - Market Intelligence Center Market Intelligence Center---Shire Plc- (NASDAQ:SHPGY) closed Tuesday's unfavorable trading session at $97.03. In the past year, the stock has hit a 52-week low of $63.92 and 52-week high of $105.53. -Shire Plc- (SHPGY) stock has been showing support - Date : Wed, 03 Aug 2011 12:08:58 GMT+00:00 |
| Shire plc: Board Changes - Sacramento Bee Sacramento Bee--By -Shire plc Shire plc- (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announces that Susan Kilsby will join the Board of Directors on September 1 st , 2011. On joining the Board, Ms Kilsby will become a member - Date : Wed, 27 Jul 2011 17:01:40 GMT+00:00 |
| Shire Raises 2011 Forecast as Quarterly Profit Beats Estimates - Bloomberg Bloomberg---Shire Plc- (SHP) raised its full-year sales forecast after reporting second-quarter profit that beat analysts' estimates on higher-than-expected revenue from the attention-deficit pill Adderall XR and ... - Date : Thu, 28 Jul 2011 15:11:00 GMT+00:00 |
| Shire Plc (SHPGY) NewsBite - SHPGY Downgraded To Neutral - Market Intelligence Center Market Intelligence Center---Shire Plc- (SHPGY) was Downgraded today by analysts at JP Morgan and the stock is now at $98.63, down $3.90 (-3.8%) on volume of 607495 shares traded. The stock was lowered to Neutral from Overweight. Over the last 52 weeks th - Date : Tue, 02 Aug 2011 18:43:22 GMT+00:00 |
| SHIRE PLC : Director/PDMR Shareholding - 4-traders (press release) 4-traders (press release)--August 3, 2011 - -Shire plc- (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company announces the release on August 2, 2011 of 67200 -Shire plc- ordinary shares (“Shares) to Graham Hetherington, Chief Financ - Date : Wed, 03 Aug 2011 14:19:46 GMT+00:00 |
| Shire Q2 Profit Rises - Quick Facts - RTT News RTT News--(RTTNews) - Biopharmaceutical firm -Shire Plc- (SHPGY: News ,SHP.L: News ) reported that its second- quarter net income rose to $205.5 million from $160.5 million in the same quarter last year. Earnings per ADS for the quarter were $1.08, up fro - Date : Thu, 28 Jul 2011 11:48:22 GMT+00:00 |
| National Pharmaceutical Council Welcomes Shire as Its Newest Member - PR Newswire (press release) PR Newswire (press release)--3, 2011 /PRNewswire-USNewswire/ -- The National Pharmaceutical Council (NPC) today welcomed global specialty biopharmaceutical company -Shire plc- as a new member. Dr. Jeffrey M. Jonas, senior vice president, specialty pharma - Date : Wed, 03 Aug 2011 16:16:12 GMT+00:00 |
| Potential Shire Plc (SHPGY) Trade Has $95.74 Breakeven - Market Intelligence Center Market Intelligence Center---Shire Plc- (NASDAQ:SHPGY) closed Thursday's favorable trading session at $101.44. In the past year, the stock has hit a 52-week low of $63.92 and 52-week high of $101.81. -Shire Plc- (SHPGY) stock has been showing support - Date : Fri, 22 Jul 2011 12:13:54 GMT+00:00 |
| Shire plc : Second Quarter 2011 Results Date Notification - July 28, 2011 - MarketWatch (press release) MarketWatch (press release)--Details can be found on our Investor Relations website http://www.-shire-.com/shireplc/en/investors . -Shire's- strategic goal is to become the leading specialty biopharmaceutical company that focuses on meeting the needs - Date : Fri, 15 Jul 2011 14:19:42 GMT+00:00 |
| Name | Annual revenue | Indication |
|---|---|---|
| Adderall XR | $1.1B | Attention Deficit Hyperactivity Disorder (ADHD) |
| Vyvanse | $318.9M | Attention Deficit Hyperactivity Disorder (ADHD) |
| Elaprase | $305.1M | Hunter syndrome (lysosomal storage disorder) |
| Pentasa | $185.5M | Gastrointestinal (Ulcerative colitis) |
| Replagal | $176.1M | Fabry disease (lysosomal storage disorder) |
| Fosrenol | $155.4M | Renal disease |
| Lialda/Mezavant | $140.4M | Gastrointestinal (Ulcerative colitis) |
| Daytrana | $78.7M | Attention Deficit Hyperactivity Disorder (ADHD) |
| Xagrid (sold as Agrylin in the U.S.) | $78.7M | Essential thrombocytosis |
| Carbatrol | $75.9M | Epilepsy |
| Calcichew (UK) | $52.8M | Calcium supplements |
| Reminyl/Reminyl XL | $34.4M | Alzheimer's disease |
| Firazyr | $0.5M | Cardiovascular (Hereditary angioedema) |
| Intuniv | Attention Deficit Hyperactivity Disorder (ADHD) |
| Name | Annual revenue | Indication | Licensee |
|---|---|---|---|
| 3TC (Lamivudine) | $140.2M | HIV | GlaxoSmithKline |
| Zeffix (Lamivudine) | $40.3M | Chronic hepatitis B | GlaxoSmithKline |
| Philadelphia-based Fortune 500 corporations (by 2009 rank) | Comcast (59) * Sunoco (78) * Cigna (129) * Aramark (189) * Crown Holdings (289) | |
| Delaware Valley-based Fortune 500 corporations (by 2009 rank) | Companies listed above, plus: AmerisourceBergen (24) * DuPont (86) * Lincoln National Corporation (256) * Campbell Soup (299) * UGI Corp. (369) * SunGard (380) * Unisys (452) * Airgas (474) | |
| Other notable Philadelphia-based businesses | Amoroso's * AppLabs * Beneficial Bank * Crozer Keystone Health System * Philadelphia Media Holdings * Radian Group * Tasty Baking * Urban Outfitters | |
| Notable Philadelphia-based professional partnerships | Ballard Spahr * Blank Rome * Cozen O'Connor * Dechert * Drinker Biddle & Reath * Duane Morris * Morgan, Lewis & Bockius * Pepper Hamilton * Saul Ewing | |
| Other notable Delaware Valley-based businesses | Aqua America * Bentley Systems * Brandywine Realty Trust * Boscov's * Carpenter Technology Corp. * GSI Commerce * Forman Mills * Liberty Property Trust * Rita's Water Ice * Vanguard * ViroPharma * Wawa * Wilmington Trust * WSFS Bank | |
| Notable Delaware Valley-based US headquarters of foreign businesses | ACE * AgustaWestland * AstraZeneca * GlaxoSmithKline * HSBC Bank USA * ING Direct * SAP America * Siemens Medical * Shire Pharmaceuticals * Sovereign Bancorp * Subaru * Teva Pharmacueticals * TD Bank | |
| Notable Delaware Valley-based division headquarters of US corporations | Acme (SuperValu) * AlliedBarton and Pinnacle Foods (Blackstone) * Keystone Helicopter (United Tech.) * Centocor (J&J) * Colonial Penn (Conseco) * Delmarva Power (Pepco Holdings) * Hercules (Ashland) * MAB Paints (Sherwin-Williams) * MBNA (Bank of America) * McNeil Laboratories (J&J) * Neoware (Hewlett-Packard) * PECO (Exelon) * QVC (Liberty Media) * Rohm and Haas (Dow Chemical) | |
RSS
